as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹837.85
Change
-39.5 (-4.5%)
Open
₹878.15
Prev. Close
₹877.35
Day High
₹880.55
Day Low
₹832.0
Volume Analysis
Traded
2,433,292
Delivered
1,122,356
Delivery %
46.13%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (22.0%)
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year EPS growth (21.0%)
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹916.81 | ₹898.68 | ₹868.26 | ₹850.13 | ₹819.71 | ₹801.58 | ₹771.16 |
| Fibonacci | ₹898.68 | ₹880.13 | ₹868.68 | ₹850.13 | ₹831.58 | ₹820.13 | ₹801.58 |
| Camarilla | ₹851.2 | ₹846.75 | ₹842.3 | ₹850.13 | ₹833.4 | ₹828.95 | ₹824.5 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-6.96%
1 Week
-6.23%
1 Month
-9.59%
3 Months
-12.45%
6 Months
+5.39%
1 Year
-10.17%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹201.68
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
10.45%
Net margin 11.26% × asset turnover 0.58x × equity multiplier 1.6x
Company Overview
Sector
Healthcare
Market Cap
₹66,565 Cr
P/E (TTM)
62.4
ROE
11.2%
Book Value
₹131.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Fortis Healthcare Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 67/100. The strongest factor is Financial Strength (97/100), while Valuation (8/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
67/100 — GoodData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has delivered good profit growth of 64.3% CAGR over last 5 years
- −Stock is trading at 6.70 times its book value
- −Company has a low return on equity of 9.87% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Fortis signed 29-year agreements for a 400+ bed Delhi hospital and a ₹567 crore loan.
Fortis subsidiary signs 29-year healthcare agreement for 400+ bed Ashok Vihar hospital; loan up to Rs 567 crore.
Fortis filed an SLP on September 16, 2026 against Delhi High Court order in Daiichi Sankyo case.
Fortis schedules investor meets on 21-22 September 2026 in Mumbai with BNP Paribas and J.P. Morgan.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,657 | 1,770 | 1,680 | 1,786 | 1,859 | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| Expenses + | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,554 | 1,553 | 1,572 | 1,676 | 1,775 | 1,759 | 1,832 | 2,008 |
| Operating Profit | 272 | 330 | 284 | 381 | 343 | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 |
| OPM % | 16.0% | 19.0% | 17.0% | 21.0% | 18.0% | 22.0% | 19.0% | 22.0% | 23.0% | 24.0% | 22.0% | 23.0% | 21.0% |
| Other Income + | 10 | 18 | 19 | 17 | 14 | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 |
| Interest | 31 | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 |
| Depreciation | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 |
| Profit before tax | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 |
| Tax % | 27.0% | 21.0% | 27.0% | 25.0% | 24.0% | 26.0% | 9.0% | 21.0% | 24.0% | 23.0% | 26.0% | 16.0% | 25.0% |
| Net Profit + | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| EPS in Rs | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 4 | 3 | 4 | 4 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 3,966 | 4,199 | 4,574 | 4,561 | 4,469 | 4,632 | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,506 |
| Expenses + | 3,857 | 4,106 | 4,220 | 4,287 | 4,238 | 4,022 | 3,626 | 4,649 | 5,196 | 5,625 | 6,195 | 7,043 | 7,375 |
| Operating Profit | 109 | 92 | 354 | 274 | 231 | 610 | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 | 2,131 |
| OPM % | 2.8% | 2.2% | 8.0% | 6.0% | 5.0% | 13.0% | 10.0% | 19.0% | 17.0% | 18.0% | 20.0% | 23.0% | 22.0% |
| Other Income + | 92 | 299 | 649 | -689 | 228 | 126 | 95 | 367 | 157 | 64 | -11 | 45 | 42 |
| Interest | 152 | 133 | 229 | 258 | 337 | 205 | 166 | 147 | 129 | 131 | 184 | 314 | 325 |
| Depreciation | 235 | 225 | 222 | 239 | 233 | 292 | 291 | 301 | 316 | 342 | 386 | 449 | 470 |
| Profit before tax | -185 | 34 | 552 | -912 | -110 | 239 | 43 | 988 | 814 | 858 | 1,007 | 1,366 | 1,378 |
| Tax % | 2.0% | -24.0% | 13.0% | 2.0% | 103.0% | 62.0% | 230.0% | 20.0% | 22.0% | 25.0% | 20.0% | 22.0% | — |
| Net Profit + | -130 | 42 | 479 | -934 | -224 | 91 | -56 | 790 | 633 | 645 | 809 | 1,064 | 1,070 |
| EPS in Rs | -3 | 0 | 8 | -19 | -4 | 1 | -1 | 7 | 8 | 8 | 10 | 14 | 14 |
| Dividend Payout % | -1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 13.0% | 10.0% | 7.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 3,585 | 3,998 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 | 8,162 | 9,141 |
| Borrowings + | 1,784 | 1,513 | 2,217 | 1,962 | 2,010 | 1,594 | 1,531 | 1,255 | 926 | 1,155 | 2,475 | 3,473 |
| Other Liabilities + | 1,760 | 1,257 | 2,227 | 2,455 | 2,875 | 2,781 | 3,216 | 4,082 | 3,921 | 4,153 | 1,985 | 2,465 |
| Total Liabilities | 7,592 | 7,232 | 9,588 | 8,479 | 11,486 | 11,036 | 10,866 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 |
| Fixed Assets + | 4,218 | 3,642 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,424 | 12,230 |
| CWIP | 228 | 226 | 268 | 226 | 450 | 204 | 165 | 193 | 228 | 542 | 407 | 434 |
| Investments | 1,464 | 1,452 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 | 243 |
| Other Assets + | 1,682 | 1,913 | 2,023 | 1,529 | 2,290 | 1,856 | 1,716 | 1,803 | 2,225 | 2,326 | 2,378 | 2,926 |
| Total Assets | 7,592 | 7,232 | 9,588 | 8,479 | 11,486 | 11,036 | 10,866 | 11,516 | 12,089 | 12,971 | 13,377 | 15,833 |
| Equity Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 24 | 195 | 966 | 493 | -179 | 172 | 485 | 865 | 822 | 1,100 | 1,424 | 1,601 |
| Cash from Investing Activity + | 213 | 122 | -1,001 | -333 | -3,279 | 63 | -131 | -501 | -372 | -889 | -780 | -1,537 |
| Cash from Financing Activity + | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -86 | -714 | 164 |
| Net Cash Flow | -66 | -37 | 225 | -513 | 799 | -627 | 212 | -153 | -21 | 125 | -70 | 228 |
| CFO/OP | 131 | 354 | 304 | 187 | 30 | 84 | 108 | 101 | 100 | 104 | 97 | 90 |
| Free Cash Flow | -181 | -162 | 689 | 437 | -261 | 35 | 274 | 750 | 367 | 172 | 591 | 673 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 15.97% | 15.71% | 14.44% | 13.22% | 12.83% | 12.02% | 11.98% | 11.87% | 11.79% | 11.65% | 11.5% | 11.4% |
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FII | 26.31% | 23.72% | 23.24% | 23.31% | 25.26% | 26.77% | 27.4% | 27.18% | 27.9% | 27.84% | 25.98% | 25.2% |
| DII | 26.55% | 29.42% | 31.14% | 32.31% | 30.73% | 30.05% | 29.46% | 29.79% | 29.14% | 29.33% | 31.35% | 32.23% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Fortis Healthcare Ltd (this stock) | 66,565 | 62.4 | 6.71 | 11.2% |
| Aster Dm Quality Care Ltd | 66,312 | 184.0 | 9.38 | 11.3% |
| Biocon Limited. | 64,275 | 88.4 | 1.88 | 1.4% |
| Glenmark Pharmaceuticals | 69,000 | 22.1 | 6.56 | 23.6% |
| Alkem Laboratories Ltd. | 63,680 | 28.0 | 4.61 | 18.9% |
| Ipca Laboratories Ltd | 50,650 | 36.9 | 6.28 | 15.7% |
| Anthem Biosciences Ltd | 49,633 | 83.6 | 16.25 | 22.3% |
Which Mutual Funds Hold Fortis Healthcare Ltd?
Frequently Asked Questions about Fortis Healthcare Ltd
Fortis Healthcare Ltd (FORTIS) closed at ₹837.85 on NSE on 25 September 2026, down 39.5 (4.5%) from the previous close.
Fortis Healthcare Ltd trades on the NSE (National Stock Exchange of India) under the symbol FORTIS.
Fortis Healthcare Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 62.4.
Fortis Healthcare Ltd has a dividend yield of 0.11%.
Fortis Healthcare Ltd's 52-week high is ₹1,105.0 and its 52-week low is ₹767.0.
Fortis Healthcare Ltd has a market capitalisation of ₹66,565 crore.
Fortis Healthcare Ltd has a TopFund Quality Score of 67/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Fortis Healthcare Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.